Calciphylaxis Treatment Market

SKU: DMMD622 | Last Updated On: Sep 24 2022 | Available Formats

>Calciphylaxis Treatment Market Expected to reach a high CAGR 11.3% 2029:

Calciphylaxis Treatment Market is segmented By Treatment Type (Drug Therapy, Hyperbaric Oxygen Therapy, Others),  By End-User (Hospital and Clinics, Ambulatory Centers, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analys is 2022-2029.

Calciphylaxis Treatment Market was worth US  billion in 2018 and is expected to grow at a high CAGR 11.3%  during the forecast period (2022-2029). Calciphylaxis is a rare disease where calcium gathers in small blood vessels of the fat and skin tissues. It causes blood clots, painful skin ulcers and even severe infections that may lead to death. The disease is mainly observed in patients with kidney failure and are on dialysis or have had a kidney transplant. Calciphylaxis can also be seen in patients without kidney diseases.

Calciphylaxis Treatment Market Dynamics

The growth in the industry is mainly due to the increasing number of ESRD prevalence globally. Globally, about 4% of ESRD patients are suffering from calciphylaxis every year. Growing number of ongoing treatment developments that are in the pipeline will strengthen the market growth in the forecast period.

In November 2017, Sanifit has completed Phase II trial of SNF472 for wound healing in uremic calciphylaxis patients.

Lack of proper availability of treatment and high cost of existing procedures is the critical restraint that hampering the market growth.

Calciphylaxis Treatment Market Industry Segmentation

Currently, there is no effective treatment for calciphylaxis, and its occurrence is associated with hyperthyroidism. However, most of the medications in calciphylaxis are focused on wound treatment and managing calcium content in the blood.

Global calciphylaxis treatment market is segmented by treatment type and by end-user.

By treatment type market is further segmented as drug therapies, hyperbaric oxygen therapy, and others. Hyperbaric oxygen therapy is the most prominent treatment, as it helps to increase oxygen delivery to the affected parts of the body and can cure the ulcer in the body.

By end-user, the market is further segmented into hospitals and clinics, ambulatory centers and others. Hospitals and clinics accounted for the significant share with increasing number of in-patients and rising dialysis patients globally. According to NIH, over 661,000 Americans have kidney failure of which 468,000 individuals are undergoing dialysis treatment.

Calciphylaxis Treatment Market



Market CAGR


Segments Covered

By Treatment Type, By End-User, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America

Calciphylaxis Treatment Market Geographical Analysis

Based on geography the market is segmented into North America, South America, Europe, Asia Pacific and Rest of the world. North America is accounted for the significant share in the global calcify.

The growth in the region is mainly contributed by the US. According to the American Kidney Fund, around 31 million US people have chronic kidney disease (CKD). The prevalence of ESRD has been doubled between 1990 and 2015 in the US. The incidence of a kidney transplant in the US is around 618 per million population.

Calciphylaxis Treatment Market Key Companies

Key players in the worldwide calciphylaxis treatment market are Amgen Inc., Smith & Nephew Plc, Medtronic, 3M, BSN Medical, ConvaTec Inc., Sanifit, and Hope Pharmaceuticals. Key players in the industry are investing in R&D and developing new therapies to be competitive in the market globally. For instance, in June 2018, Hope Pharmaceuticals has started enrollment of candidates for Phase III study of Sodium Thiosulfate on calciphylaxis-related pain in Canada and the US at CALISTA center.

Frequently Asked Questions

What is the Projected CAGR value of the Calciphylaxis Treatment Market?

Calciphylaxis Treatment Market is expected to grow at a CAGR of 11.3% during the forecasting period 2022-2029.

Which region controlled the global market during 2022-2029?

North America region Controls the Calciphylaxis Treatment Market during 2022-2029

Which is the fastest growing region in the Calciphylaxis Treatment Market?

Among all regions, Asia Pacific is the fastest growing market share during the forecast period 

Trending Topics

Achalasia Treatment Market

Nasal Polyps Treatment Market

Aplastic Anemia Market

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!